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Introduction
Cardiovascular diseases (CVD) are one of the leading causes of morbidity and mortality in both sexes worldwide and 
even in Iran.1 Although CVD incidence in  premenopausal 
women is low, however after menopause, CVD increase faster.2 
The prevalence of CVD has raised as a result of lifestyle change 
during recent decades.3 Several risk factors including obesity, dys-
lipidemia, high blood pressure, and smoking are associated with 
higher CVD incidence.4 There are variables that may enhance the 
discrimination of persons at high risk for CVD. Previous studies 
declared that waist circumference (WC) is related with visceral 
adipose tissue and correlated with metabolic abnormalities.5 Cen-
tral obesity is strongly associated with all metabolic disorders, 
cancers, and cardiovascular risk,6 but WC alone could not differ-
entiate intra-abdominal from subcutaneous abdominal adiposity.7 
Therefore, in individuals with increased WC, high triglycerides 
(TG) concentration could be used as an indicator for adipose tis-
sue and metabolic complications.8 Moreover, fasting TG level 
could be considered as an excellent predictor for LDL-cholesterol 
(LDL-C) particle size.9
High fasting TG and increased WC levels have been recognized 
as high-risk metabolic abnormality.10 Elevated TG elevated WC 
that mean WC more than 90 cm in males or 85 cm in females 
together with fasting 7*OHYHOVKLJKHUWKDQPJG/LVGH¿QHG
as hyper triglyceridemic waist phenotype has been revealed as 
strong predictor for CVD.11,12 Attempts to simplify the screening 
for CVDs to promote wider use introduced this phenotype as less-
expensive measure for CVD risks such as insulin resistance, high 
apolipoprotein (Apo) B/A ratio, and high LDL-C level.13
$VLJQL¿FDQWLQFUHDVHLQ&9'ULVNVRFFXUVIROORZLQJWKHPHQR-
pause transition.14 This increase is partially caused by changes in 
plasma lipoproteins levels which happen subsequent to estrogen 
GH¿FLHQF\15 Moreover, it has been shown that the menopause 
transition is related with harmful changes in the distribution of 
body fat, particularly, central obesity is increased;16 however, the 
risk of central obesity for CVD remained even after adjusting the 
parity effect in menopausal women in Iran.17 For many years, it 
was controversial that higher CVD risk could be as a result of 
aging or a consequence of menopause, or both.18 A recent meta-
DQDO\VLV IRXQG QR VLJQL¿FDQW DVVRFLDWLRQ between menopausal 
transition and CVD after controlling for probable confounders.19 
Another report suggested that in postmenopausal women, older 
age may be responsible for cardiovascular risk by stimulating 
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ischemic damage in the ovaries or endocrine changes,20 and some 
have inquired if menopause concerns with cardiovascular risk.18 
Furthermore,  the presence of TG/WC phenotype has been sug-
gested as one of the best markers of CVD risk.21 The aim of this 
study was to investigate the prevalence of hyper- TG/WC phe-
notype in pre- and postmenopausal women and the menopause 
effect on CVD risk factors in women with elevated TG and WC.
Subjects and Methods
Participants
Derived from multistage cluster random sampling method, 
above 12000 participants, from three districts of Isfahan, Arak, 
and Najafabad in three phases were selected form Isfahan Healthy 
Heart Program (IHHP). IHHP was a community-based interven-
tional program that was conducted by Isfahan Cardiovascular Re-
VHDUFK,QVWLWXWHDQG,VIDKDQ3URYLQFLDO+HDOWK2I¿FHZLWKWKHDLP 
of CVD prevention and healthy lifestyle promotion.
Additional information concerning IHHP design and sampling 
process was presented in previous publications.1,22 For this cross-
sectional study, we used information from the initial phase of 
IHHP. Based on our inclusion criteria that was consisted of hav-
LQJ JOXFRVH DQG OLSLG SUR¿OHV GLHWDU\, socio-demographic, and 
anthropometric information, a total of 4146 women were selected 
for this study. A written informed consent was taken from each 
participant. Isfahan University of Medical Sciences Ethics Com-
mittee has approved this study.
Anthropometric Assessment
Measurement of weight and height was completed by expert 
technicians while individuals had light clothes and no shoes. 
Weight of the participants was measured using a calibrated scale 
and height was measured by a measuring tape. Calculation of 
body mass index (BMI) was based on the formula (weight in ki-
logram divided by squared height in meters [kg/m2]). WC was 
measured horizontally between lowest rib and the iliac crest and 
the greatest point of hip was measured for hip circumference.
Biochemical Assessment
Fasting blood samples were collected while participants were 
overnight fasting. After taking plasma, blood samples were frozen 
and sent to Isfahan Cardiovascular Research Institute central labo-
ratory for further assessment. Fasting plasma glucose (FPG), se-
rum total cholesterol, and triglyceride levels were measured using 
enzymatic colorimetric method. Serum HDL-C was determined 
after removing non-HDL-C using dextran sulfate-magnesium 
chloride. Friedewald equation23 was used to calculate LDL-C 
level. 
Other Variables Assessment
Data regarding socio-demographic, smoking habit, family his-
tory, and menopause situation were gathered by a pretested ques-
tionnaire. Physical activity was assessed using Baecke question-
naire.24
Statistical Methods
WeXVHG6366VRIWZDUHIRURXUVWDWLVWLFDODQDO\VLVDQG3 
was used for statistical differences. Two independent sample t-
test was applied to compare means of continuous variables and 
to compare categoric variables, chi-square test was used. To test 
the differences between pre- and post- menopause in hyper- TG/
WC and other groups we used ANCOVA test in adjusted models. 
7KH¿UVWDGMXVWPHQWZDVPDGHIRUDJHDQGIXUWKHU adjustment was 
made for BMI.
Results
Analyses were done on 4146 women, 2947 premenopausal and 
1199 postmenopausal. The prevalence of hyper- TG/WC and its 
components in pre- and postmenopausal women are showed in 
)LJXUH7ZHQW\¿YHSRLQWWKUHHSHUFHQWRI the postmenopausal 
women and 9.5% of the premenopausal women were hyper- TG/
WC; however, elevated WC group allocated the highest percent-
age and the percentages of the postmenopausal women were 
higher than the premenopausal women in all groups. Character-
istics of the study participants based on menopausal status are 
shown in Table 1. In comparison with postmenopausal women, 
premenopausal women are more physically active, with higher 
education level, and less likely to be smoker. Postmenopausal 
women tended to have elevated BMI, WC, and waist to hip ratio. 
1RVLJQL¿FDQWGLIIHUHQFHVZHUH IRXQG in the weight of the two 
groups. Cardiovascular risk factors of the study participants are 
provided in Table 2. In post-menopausal women, biochemical 
factors including FBS, cholesterol, HDL, LDL, CRP (C-reactive 
protein), Apo A, Apo B, and TG OHYHOVDUHVLJQL¿FDQWO\KLJKHU
than  premenopausal women. 
The cardiovascular risk factors of the study participants based 
on the presence of hyper- TG/WC in pre- and postmenopausal 
Pre- menopause (n=2944, 71%) Post- menopause (n = 1199, 29%) P- value
Age (years) 32.15 ± 0.17 59.80 ± 0.30 0.000
Physical activity (mets/sec) 709.45 ± 7.33 570.45 ± 11.15 0.000
Smoking (%) 0.6 1.3 0.035
Educatio n (%) 0.000
0–5 years 43.4 88.6
6-12 years 44.6 9.6
>12 years 12.0 1.8
Weight  (kg) 66.32 ± 0.23 66.27 ± 0.37 0.91
BMI(kg/m2) 26.20 ± 0.09 27.57 ± 0.13 0.000
Waist circumference (cm) 88.73 ± 0.25 97.10 ± 0.37 0.000
Waist to hip ratio 0.87 ± 0.001 0.96 ± 0.002 0.000
*Data are means ± standard error unless indicated.
Table 1. Characteristics of the study participants based on menopausal status*
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groups are presented in Table 3. In premenopausal group, indi-
viduals with hyper- TG:&SKHQRW\SHKDYHVLJQL¿FDQWO\KLJKHU
level of FBS, total cholesterol, LDL-C, CRP, Apo A, Apo B, and 
TG levels but lower level of HDL-C. The percentages of meta-
bolic syndrome and diabetes are also higher in this phenotype. In 
postmenopausal group, except for CRP and Apo A, similar trend 
have been shown for other metabolic risk factors. All of the risk 
IDFWRUVDUHVLJQL¿FDQWO\KLJKHULQSRVWPHQRSDXVDOZRPHQ7DEOH 
4 demonstrates multivariate-adjusted means and standard error of 
cardiovascular risk factors for menopause in different phenotypes 
of WC and TG groups after adjustment for age. In hyper- TG/
WC group, FBS is higher in postmenopausal women but not af-
ter further adjustment for BMI. In normal-TG/WC group, total 
cholesterol and LDL-C increase after menopause but they did not 
UHPDLQVLJQL¿FDQWDIWHUDGGLWLRQDODGMXVWPHQWIRU%0,7KHUHLV 
no difference for other groups and other risk factors.
Discussion
The objective of the current study was to compare the prevalence 
of hyper- TG/WC between pre- and postmenopausal women and 
to test whether menopause, independent of other variables, can be 
associated with CVD risk factors in women with hyper- TG/WC 
phenotype. During recent decades life expectancy for women has 
increased to 74.6 years; it means they live about one-third of their 
lives in the postmenopausal state,25 thus realizing the effect of 
menopause on women’s health  is becoming ever more important. 
In this cross-sectional analysis on women from IHHP study, the 
postmenopausal women had higher BMI, WC, and waist to hip 
ratio compared with the premenopausal women. Our observed 
trend is consistent with others that found an increase in BMI after 
menopause26 and revealed that in the menopausal transition, BMI 
LVDVLJQL¿FDQWmediator of sexual hormone level.27 It has been as-
sumed that the relation between menopause and obesity is linked 
with adipose-derived markers such as leptin, adiponectin, or in-
sulin resistance28  independent of age and race;29 however, others 
VSHFL¿HGthat increasing in body fat after menopause is associated 
with both menopause transition and aging.30
Greater android fat distribution in postmenopausal women is as-
sociated with diabetes and CVD risk.31 DQGDGYHUVHOLSLGSUR¿OHV
such as lower HDL-C and higher LDL-C, total cholesterol, and 
TG levels.32 The current study showed that in the postmenopausal 
women, lipid SUR¿OHVZHUHKLJKHUWKDQWKHSUHPHQRSDXVDOZRP
en. Some of the previous published studies have also reported 
higher level of TG,33 total cholesterol, and LDL-C in postmeno-
pausal women.34 Conversely, evidence about the association be-
tween HDL-C and menopause is inconsistent.35 We observed that 
HDL-C and Apo A increased in postmenopausal women. On the 
contrary to previous investigations indicating a gradual decrease 
in HDL-C in postmenopausal women,35 our results is in line 
with others showing a gradual increase in HDL-C after meno-
pause transition.35 It has been hypothesized that total cholesterol 
increase could also affect other lipids like HDL-C. In addition, 
since lipids and menopause are highly associated with age, it is 
Pre- menopause (n = 2944, 71%) Post- menopause (n = 1199, 29%) P- value
FBS (mg/dL) 87.32 ± 17.46 103.14 ± 36.43 0.000
Triglycerides(mg/dL) 127.82 ± 81.24 185.02 ± 123.14 0.000
Cholesterol (mg/dL) 186.74 ± 38.10 225.60 ± 43.10 0.000
HDL (mg/dL) 46.42 ± 10.68 47.77 ± 11.63 0.001
LDL (mg/dL) 114.93 ± 31.64 140.51 ± 35.33 0.000
CPR (mg/dL) 3.46 ± 3.18 3.75 ± 3.33 0.01
Apo A (mg/dL) 125.45 ± 24.19 137.03 ± 25.39 0.000
Apo B (mg/dL) 94.50 ± 23.02 113.04 ± 25.32 0.000
*Data are means± standard deviation. 
Table 2. Metabolic risk factors of the study participants based on menopausal status*
Figure 1. The prevalence of hyper triglyceridemic high WC in pre- and post menopausal women.
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QRWFOHDUWKDWLQFUHDVLQJLQOLSLGSUR¿OHVis independent of age ef-
fects35 and some suggested that menopause effect is similar to the 
consequence of older age.34 Although there is evidence that after 
adjusting for age and BMI, menopause was still a predictor for 
metabolic syndrome,36DQRWKHUODUJHVWXG\GLGQ¶W¿QGDQ\VLJQL¿-
cant differences inOLSLGSUR¿OHVDIWHUDGMXVWPHQWIRUDJH30
Although previous studies showed the rising trend in overweight 
and hyper- TG/WC in Iranian population,37 the present investiga-
tion found that the prevalence of hyper- TG/WC and also high TG 
or high WC were higher in the postmenopausal women. More-
over in pre- and postmenopausal groups, most of the cardiovascu-
lar risk factors were worse in hyper-TG/WC subgroups. 
Hyper- TG/WC phenotype is an important predictor for CVD 
risk8 and as our result shows women in the hyper- TG/WC group 
in both menopausal subgroups had worse situation. A previous 
study showed that larger WC, independent of BMI, was positively 
associated with cardiovascular risk.38 Consequently, it was sug-
gested to measure the WC besides BMI to estimate the amount 
of adiposity.8 In addition, the presence of small, dense LDL has 
been associated with higher fasting TG levels.39 In this regards, it 
Pre- menopause Post- menopause
P- valueHyper- TG / WC Normal- TG / WC P-value Hyper- TG / WC Normal- TG / WC P- value
Metabolic syndrome (%) 93.2 13.9 0.000 95.7 43.0 0.000 0.000
Diabetes (%) 11.1 2.2 0.000 28.9 16.8 0.000 0.000
FBS (mg/dL) 94.91 ± 31.25 84.05 ± 13.67 0.000 112.82 ± 50.24 96.16 ± 29.66 0.000 0.000
Triglycerides (mg/dL) 297.52 ± 117.55 108.79 ± 48.46 0.000 312.10 ± 140.50 138.62 ± 62.60 0.000 0.000
Cholesterol (mg/dL) 226.23 ± 41.29 182.73 ± 35.27 0.000 245.77 ± 44.34 217.20 ± 38.37 0.000 0.000
HDL (mg/dL) 38.78 ± 10.01 47.29 ± 10.42 0.000 41.39 ± 10.30 49.47 ± 11.35 0.000 0.001
LDL (mg/dL) 129.54 ± 37.32 113.70 ± 30.39 0.000 143.03 ± 39.64 139.38 ± 33.48 0.190 0.000
CPR (mg/dL) 3.88 ± 3.50 3.28 ± 2.99 0.009 3.94 ± 3.01 3.59 ± 3.29 0.152 0.011
Apo A (mg/dL) 131.44 ± 25.98 124.03 ± 23.73 0.000 138.00 ± 25.21 135.94 ± 24.67 0.258 0.000
Apo B (mg/dL) 113.93 ± 26.54 92.16 ± 29.66 0.000 123.65 ± 26.80 108.39 ± 23.03 0.000 0.000
*Data are means± standard deviation unless indicated.
Table 3. Metabolic risk factors of the study participants based on menopausal status and the presence of hypertriglyceridemic waist phenotype*
Hyper- TG / WC Normal- TG hyper- WC Hyper- TG normal- WC Normal- TG / WC
Menopause Pre- menopause Menopause
Pre- 
menopause Menopause Pre- menopause Menopause Pre- menopause
FBS
Model 1 105.19 ± 2.69̅ 95.41 ± 2.54 90.18 ± 2.52 86.68 ± 2.26 101.920 ± 4.06 94.68 ± 3.29 83.48 ± 2.82 86.11 ± 2.30
Model 2 105.07 ± 2.70 95.14 ± 2.57 89.99 ± 2.52 86.45 ± 2.28 102.90 ± 4.10 94.72 ± 3.29 83.74 ± 2.85 86.30  ± 2.33
Total cholesterol
Model 1 229.01 ± 4.14 226.34 ± 3.89 199.46 ± 3.86 193.88 ± 3.47 231.91 ± 6.23 228.39 ± 5.04 197.61 ± 4.33̅ 182.71 ± 3.53
Model 2 227.32 ± 4.2 222.72 ± 3.92 198.10 ± 3.85 191.39 ± 3.48 233.99 ± 6.26 229.40 ± 5.02 200.98 ± 4.35 185.88 ± 3.55
LDL- cholesterol
Model 1 131.81 ± 3.66 128.31 ± 3.42 130.93 ± 3.45 124.86 ± 3.08 133.99 ± 5.52 138.61 ± 4.47 126.97 ± 3.84̅ 114.83 ± 3.13
Model 2 130.29 ± 3.65 127.69 ± 3.47 127.12 ± 3.42 122.62 ± 3.08 135.66 ± 5.55 139.53 ± 4.45 128.03 ± 3.85 117.69 ± 3.15
HDL- cholesterol
Model 1 39.47 ± 1.22 38.06 ± 1.15 47.85 ± 1.14 45.66 ± 1.02 37.05 ± 1.84 38.19 ± 1.49 49.66 ± 1.28 48.49 ± 1.04
Model 2 39.69 ± 1.22 38.57 ± 1.16 48.05 ± 1.14 46.06 ± 1.03 36.67 ± 1.85 38.05 ± 1.49 49.09 ± 1.29 48.02 ± 1.05
Apo A
Model 1 131.45 ± 2.84 130.76 ± 2.67 129.62 ± 2.65 125.16 ± 2.38 128.79 ± 4.30 134.45 ± 3.47 129.89 ± 2.97 125.03 ± 2.42
Model 2 131.52 ± 2.84 131.01 ± 2.70 129.53 ± 2.66 125.36 ± 2.39 128.83 ± 4.35 134.38 ± 3.47 129.59 ± 3.00 124.82 ± 2.45
Apo B
Model 1 114.59 ± 2.52 115.72 ± 2.38 100.02 ± 2.36 101.07 ± 2.12 107.19 ± 3.83 118.44 ± 3.09 97.19 ± 2.65 95.29 ± 2.15
Model 2 113.95 ± 2.52 114.41 ± 2.39 99.62 ± 2.36 100.18 ± 2.13 107.56 ± 3.86 118.81 ± 3.09 98.35 ± 2.67 96.46 ± 2.17
CRP
Model 1 3.45 ± 0.38 3.81 ± 0.36 3.15 ± 0.36 3.57 ± 0.32 3.11 ± 0.56 4.21 ± 0.46 2.90 ± 039 3.28 ± 0.32
Model 2 3.44 ± 0.38 3.78 ± 0.36 3.13 ± 0.36 3.56 ± 0.32 3.10 ± 0.57 4.22 ± 0.46 2.93 ± 0.40 3.30 ± 0.30
Model 1: Adjusted for age, Model 2: Further adjusted for BMI.
Table 4. Multivariate-adjusted means ( ± SE) of cardiovascular risk factors for menopause in different waist circumference and triglycerides 
phenotype groups  
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has been proposed that the presence of adiposity combined with 
K\SHU7*FRXOGEHXVHGDV¿UVW screening tool to identify the fu-
ture risk of metabolic syndrome and CVD risk.8 Because of some 
GLI¿FXOWLHVDFFHVVLQJQHZ markers of CVD risk, a simple, inex-
pensive, and practical screening method  to identify this metabolic 
risks is critical.40
The effect of independent role of menopause than that of age 
remains controversial41 and estrogen replacement in postmeno-
pausal women didn’t improve coronary mortality or morbidity.42 
It has been suggested that it is not menopause that has negative 
effect on cardiovascular risk but the age at menopause is a deter-
minant factor.20
Although in postmenopausal women compared with premeno-
pausal women, the incidence and prevalence of CVD are higher,41 
it is not clear which factor is responsible for this situation and this 
could not predict CVD risk, while hyper- TG/WC phenotype can 
be a better predictor.
There were several limitations that should be considered in the 
explanation of RXU¿QGLQJV7KHGHVLJQRIRXUVWXG\ZDVFURVV
sectional that disallows inferring causal relationship between 
menopause and cardiovascular risk factors. Further longitudinal 
studies could conclude the effect of menopause transition on car-
diovascular risk factors. Moreover, some lifestyle parameters, 
might confounding the association between hyper- TG/WC phe-
notype, menopause, and CVD risk factors, may not fully con-
trolled and obtained in our analysis.
Based on the results of the current study, menopause is not inde-
pendently associated with CVD risk and hyper- TG/WC pheno-
type is a better predictor for CVD risk. Although further prospec-
WLYHVWXGLHVDUHPDQGDWRU\WRFRQ¿UPWKLVDVVRFLDWLRQpostmeno-
pausal women should be aware of their increasing cardiovascular 
risk and pay more attention to monitor their CVD risk factors 
particularly WC and TG levels.
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